<p>(A) Sensitivity of a panel of NSCLC lines to inhibition of growth by 10 µM BPTES in a 72 hr proliferation assay. Growth rates (mu) plotted relative to DMSO control for each cell line (mu/max). (B,C) A427 parent cells or cells stably expressing an empty vector control (Con), wild-type GAC (GAC), or a BPTES-resistant GAC enzyme (GAC-BR) were treated with the indicated concentrations of BPTES (A) or the inactive BPTES analogue, AGX-4769 (C), in a 72 hr proliferation assay. Results are representative of three independent experiments with mean and standard deviation indicated. (D,E) Measurement of isotopomer labeled <sup>13</sup>C(5)-Glu (D) or <sup>13</sup>C(4)-Asp (E) from cells treated for 4 hr with BPTES or with inactive analogue AGX-4769...
<p>(A) Cell viability assay. CNE1, CNE2, HONE1 and C666-1 cells were treated with various doses of S...
<p><b>(</b>A) Inhibition of GBM cell line proliferation following culture with CID613034 (black, 0 μ...
<p>BTICs were incubated with 1 µM Sunitinib or 0.00025% DMSO (control), and the XTT proliferation as...
<p>(A). HNSCC cells were treated with BME for 24 h, and MTS assay was performed. (B). Cal27 cells we...
<p>For determination of anti-proliferative activity, the cancer cell lines (<i>i</i>.<i>e</i>., HL-6...
<p>Immunofluoresent analysis of BPCs stained with DiI-acLDL (red), Isolectin B4 (green), nuclei (blu...
<p>(a) ABCB6 expressing cells showed dose dependent decrease in median channel fluorescence (represe...
<p>The viability curves of B cells and PBMCs after four days of incubation with different concentrat...
<p>(A): Te 85 clones were plated at a 10<sup>5</sup> cells/ml in 6 well plates in cell culture mediu...
<p>(<b>A</b>) <b>BrdU incorporation assay.</b> SMS-KCNR NB cells were treated with various concentra...
Currently, biocompatibility assays based on USP Class VI or ISO 10993 standards are known to be unsu...
<p>(A) Analysis of the general toxicity of compound treatment. The total cell numbers in each well w...
<p>Trypan blue dye exclusion viability assay in BPCs treated with 5Aza and TSA <b>(A)</b>. Prolifera...
A panel of human prostate and cancer cells were seeded in a 96-well plate at optimized conditions (d...
<p>(A) MSCs from Mutant, Lean and Control, were measured for proliferation rate at 24, 48, 72 and 96...
<p>(A) Cell viability assay. CNE1, CNE2, HONE1 and C666-1 cells were treated with various doses of S...
<p><b>(</b>A) Inhibition of GBM cell line proliferation following culture with CID613034 (black, 0 μ...
<p>BTICs were incubated with 1 µM Sunitinib or 0.00025% DMSO (control), and the XTT proliferation as...
<p>(A). HNSCC cells were treated with BME for 24 h, and MTS assay was performed. (B). Cal27 cells we...
<p>For determination of anti-proliferative activity, the cancer cell lines (<i>i</i>.<i>e</i>., HL-6...
<p>Immunofluoresent analysis of BPCs stained with DiI-acLDL (red), Isolectin B4 (green), nuclei (blu...
<p>(a) ABCB6 expressing cells showed dose dependent decrease in median channel fluorescence (represe...
<p>The viability curves of B cells and PBMCs after four days of incubation with different concentrat...
<p>(A): Te 85 clones were plated at a 10<sup>5</sup> cells/ml in 6 well plates in cell culture mediu...
<p>(<b>A</b>) <b>BrdU incorporation assay.</b> SMS-KCNR NB cells were treated with various concentra...
Currently, biocompatibility assays based on USP Class VI or ISO 10993 standards are known to be unsu...
<p>(A) Analysis of the general toxicity of compound treatment. The total cell numbers in each well w...
<p>Trypan blue dye exclusion viability assay in BPCs treated with 5Aza and TSA <b>(A)</b>. Prolifera...
A panel of human prostate and cancer cells were seeded in a 96-well plate at optimized conditions (d...
<p>(A) MSCs from Mutant, Lean and Control, were measured for proliferation rate at 24, 48, 72 and 96...
<p>(A) Cell viability assay. CNE1, CNE2, HONE1 and C666-1 cells were treated with various doses of S...
<p><b>(</b>A) Inhibition of GBM cell line proliferation following culture with CID613034 (black, 0 μ...
<p>BTICs were incubated with 1 µM Sunitinib or 0.00025% DMSO (control), and the XTT proliferation as...